Insights Center
ML Strategies Viewpoints
Search
Showing 49 - 56 of 492 results
Congress’ Lame Duck Priorities in Telecom
November 1, 2018|Advisory
ML Strategies Weekly Health Care Preview - October 9, 2018
October 19, 2018|Blog
ML Strategies October 2018 Election Update
October 10, 2018|Advisory
Celebrating the Promise of Parity and the Path Forward
October 9, 2018|Blog
ML Strategies Weekly Health Care Preview - Week of September 24th
September 24, 2018|Blog
ML Strategies Health Care Preview - Week of September 17th
September 17, 2018|Blog
ML Strategies 2018 Election Preview
September 11, 2018|Advisory
ML Strategies Weekly Health Care Preview – September 10, 2018
September 10, 2018|Blog
News & Press Releases
To Pitch Pre-Cert to Congress, FDA Builds a Case First
September 26, 2019 | MedTechDive
MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.
Former FDAer Defends FDA Decision to Withdraw Data Falsification Rule
August 20, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
Events
Nov
8
2019